Cargando…
107例KRAS突变阳性非小细胞肺癌患者临床分析
BACKGROUND AND OBJECTIVE: Kirsten rat sarcoma viral oncogene (KRAS) mutation is one of the major driver genes of non-small cell lung cancer (NSCLC). KRAS is a resistant predictor of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), which raises controversy because of its role...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973060/ https://www.ncbi.nlm.nih.gov/pubmed/27215453 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.05.02 |